The short version
Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.5592 per unit over the past year.
Market view
asprin and extended-release dipyridamole
2 marketed package NDCs · 1 active manufacturer
Most dispensed: ASPIRIN 25 mg; DIPYRIDAMOLE 200 mg · Capsule · #60 capsules/bottle
Price range and competition
RSS: changes for this drugEvery company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $0.5592 · middle half $0.5592–$0.5592 · full range $0.5592–$0.5592 · 1 products · 1 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for asprin and extended-release dipyridamole, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Asprin And Extended-Release DipyridamoleAug 19, 2026Price downNADAC $0.56375 → $0.55922 per unit (-0.8%)
- Asprin And Extended-Release DipyridamoleJul 22, 2026Price downNADAC $0.5727 → $0.56375 per unit (-1.56%)
Same drug class
Other molecules FDA puts in Platelet Aggregation Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- acetaminophen , aspirin and caffeine· 1 maker
- acetaminophen 250 mg aspirin 250 mg caffeine 65 mg· 1 maker
- acetaminophen 250 mg, aspirin 250 mg, and caffeine 65 mg· 1 maker
- acetaminophen 250mg, aspirin 250mg and caffeine 65mg· 1 maker
- acetaminophen and asprin· 1 maker
- acetaminophen-aspirin-caffeine· 1 maker
- acetaminophen, aspirin (nsaid) and diphenhydramine citrate· 1 maker
- acetaminophen, aspirin, caffeine tablet· 1 maker
- acetaminophen, aspirin, caffeine tablet, film coated· 1 maker
- acetaminophen, asprin, caffeine· 1 maker
- acetaminophen, caffeine, aspirin tablet· 1 maker
- acetaminophen/aspirin/caffeine tablet· 1 maker
Common questions
- Is Asprin and extended-release dipyridamole in shortage right now?
- No. FDA does not currently list Asprin and extended-release dipyridamole in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Asprin and extended-release dipyridamole?
- 1 company has marketed Asprin and extended-release dipyridamole in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
- What does Asprin and extended-release dipyridamole cost?
- The typical pharmacy pays about $0.5592 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.